Still casflow negative to $1m if you take out the R&D grant. They really distort to look positively the numbers with selective reporting.
Comparing 1H23 minus Covid. Suited them to crow on about sales of covid RAT's then but now where comparing revenues to 1H24.
Also in the amount of quarters they claim 26 quarters (6.5m /0.249k) of funding when it is acutally 6.5 ($6.5/1m) when R&D grant of $761k is added in. Govt R&D is not revenue from product sales.
Its a shifty company in its reporting which reflects on managements trying to appear things are going swimmingly well. Must be a dumb board who never look at the numbers forensicaly.
- Forums
- ASX - By Stock
- Ann: Quarterly Activity Report - 31 December 2023
AT1
atomo diagnostics limited
Add to My Watchlist
0.00%
!
1.8¢

Still casflow negative to $1m if you take out the R&D grant....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.17M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $5.663K | 314.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1086574 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 1420585 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1086523 | 0.018 |
4 | 2308397 | 0.017 |
13 | 2263668 | 0.016 |
8 | 1699284 | 0.015 |
11 | 4613347 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 1470585 | 7 |
0.020 | 1854933 | 4 |
0.021 | 1005868 | 7 |
0.022 | 573894 | 6 |
0.023 | 371636 | 5 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |